About Us

Who we are

Ms. Dally has more than 20-years of experience in the biotechnology, pharmaceutical , medical device and medical technology industries as an investor relations advisor, healthcare fund analyst, business development and medical device marketing management, and microbiologist.

Janet L. Dally

Before founding Maidstone Life Sciences LLC, she was Senior Partner at MD Becker LLC. Prior to joining MD Becker Partners , Ms. Dally was President of MontRidge, LLC, a boutique investor relations and strategic consulting firm specializing in the life science industry. She first joined MontRidge as Vice President in 1998. During her tenure at MontRidge, Ms. Dally built meaningful relationships with the executive management of life science clients and the US and European investment community resulting in increased institutional ownership, diversified shareholder base, sell-side analyst coverage, enhanced valuation and successful financing. She was Vice President of Investor Relations at Burns McClellan, a life sciences communication firm.

Ms. Dally has 6-years experience as a buy-side portfolio analyst evaluating and recommending biotechnology, pharmaceutical, medical device and healthcare services firms for the Merrill Lynch Healthcare Fund.

Ms. Dally also has experience in the pharmaceutical and Medical Device industries Sterling Drug/Kodak, Forest Laboratories and CR Bard where she held management positions in strategic planning, business development, licensing and M&A and product management

She acquired a n M.B.A. from the Tepper School of Business, Carnegie Mellon University, an M.S. in Microbiology from Wagner College and a B.S. in Medical Technology from Rutgers University.